Article Details

Trillium buyout keeps premiums keen - Evaluate Pharma

Retrieved on: 2021-08-25 14:48:05

Tags for this article:

Click the tags to see associated articles and topics

Trillium buyout keeps premiums keen - Evaluate Pharma. View article details on HISWAI: https://www.evaluate.com/vantage/articles/insights/ma/trillium-buyout-keeps-premiums-keen

Excerpt

One of these was Jazz's acquisition of GW Pharmaceuticals, which at $7.1bn is 2021's biggest biopharma M&A deal so far. That transaction was struck at a 51% ...

Article found on: www.evaluate.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up